title: Biomarkers for systemic lupus erythematosus.
abstract: The urgent need for lupus biomarkers was demonstrated in September 2011 during a Workshop sponsored by the Food and Drug Administration: Potential Biomarkers Predictive of Disease Flare. After 2 days of discussion and more than 2 dozen presentations from thought leaders in both industry and academia, it became apparent that highly sought biomarkers to predict lupus flare have not yet been identified. Even short of the elusive biomarker of flare, few biomarkers for systemic lupus erythematosus (SLE) diagnosis, monitoring, and stratification have been validated and employed for making clinical decisions. This lack of reliable, specific biomarkers for SLE hampers proper clinical management of patients with SLE and impedes development of new lupus therapeutics. As such, the intensity of investigation to identify lupus biomarkers is climbing a steep trajectory, lending cautious optimism that a validated panel of biomarkers for lupus diagnosis, monitoring, stratification, and prediction of flare may soon be in hand.
authors.affiliation: Lupus Center of Excellence, Department of Medicine, Allegheny Singer Research Institute, West Penn Allegheny Health System and Temple University School of Medicine, 320 E. North Avenue, Pittsburgh, PA 15212, USA. jahearn@wpahs.org.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Ahearn
authors.forename: Chau-Ching
authors.initials: CC
authors.lastname: Liu
authors.forename: Amy H
authors.initials: AH
authors.lastname: Kao
authors.forename: Susan
authors.initials: S
authors.lastname: Manzi
mesh_terms: D015415:Biomarkers / Q000378:metabolism*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000453:epidemiology / Q000378:metabolism*; D011237:Predictive Value of Tests; D012307:Risk Factors
chemical_list: D015415:Biomarkers